Halozyme Therapeutics, Inc.【HALO】 経常(税引前)利益の推移

機能の使い方
(単位:千ドル) 経常(税引前)利益 前年比(%)
4Q25 -100,849 -156.6%
3Q25 218,958 +32.6%
2Q25 204,938 +74.1%
1Q25 143,828 +49.8%
4Q24 178,214 +76.1%
3Q24 165,147 +62.3%
2Q24 117,743 +26.4%
1Q24 96,028 +83.8%
4Q23 101,175 +42.9%
3Q23 101,760 +38.1%
2Q23 93,156 +210.4%
1Q23 52,238 -29.8%
4Q22 70,791 +29.2%
3Q22 73,707 -0.5%
2Q22 30,011 -67.2%
1Q22 74,409 +164.9%
4Q21 54,810 -25.2%
3Q21 74,106 +104.3%
2Q21 91,516 +253.7%
1Q21 28,086 -561.0%
4Q20 73,249 -312.6%
3Q20 36,270 -245.1%
2Q20 25,875 -277.1%
1Q20 -6,092 -435.1%
4Q19 -34,460 +1804.9%
3Q19 -25,002 -10.2%
2Q19 -14,607 -36.1%
1Q19 1,818 -106.7%
4Q18 -1,809 -101.5%
3Q18 -27,850 -936.6%
2Q18 -22,860 -25.3%
1Q18 -27,274 -16.6%
4Q17 121,551 -537.1%
3Q17 3,329 -112.0%
2Q17 -30,583 +15.1%
1Q17 -32,687 -
4Q16 -27,808 -
3Q16 -27,662 -
2Q16 -26,575 -